
MBBS, MD, DCH
Consultant in pediatric endocrinology specializing in hormonal and growth disorders in children
Experience
—
Languages
English
Location
Al Jaddaf, Dubai
Sees
children
Dr. Nandu Thalange is a Consultant in Pediatric Endocrinology at Al Jalila Children's Hospital, part of Dubai Health. He specializes in diagnosing and managing complex hormonal and growth-related conditions in children, drawing on extensive international training and clinical expertise.
Dr. Thalange's clinical practice covers pediatric diabetes, thyroid disorders, growth and puberty concerns, adrenal conditions, and metabolic bone health. He is known for a patient-centered approach that combines evidence-based medicine with compassionate care tailored to each child's individual needs and family circumstances.
He brings experience in senior consultant roles and has been actively involved in clinical leadership to develop specialized services for children with endocrine disorders. He consults in English and is committed to supporting young patients and their families through long-term endocrine care.
Extracted from the doctor's hospital profile — patient-friendly terms
MBBS
MD
DCH
Consultant in Pediatric Endocrinology
Al Jalila Children's Hospital, United Arab Emirates
Consultations are available in English.
Dubai Health — Al Jalila Children's Hospital, Al Jaddaf, Dubai.
Yes — this doctor sees children.
Commonly treated: Adrenal Conditions, Growth Disorders, Metabolic Bone Disease, Pediatric Diabetes, Puberty Concerns, Thyroid Disorders in Children.
Profile compiled from Dubai Health's public website (see original profile via the booking link). Data is informational, not medical advice.
Al Jalila Children's Specialty Hospital: 3.4★ · 1,204 Google reviews — Google rating for the clinic, not this doctor.
No patient reviews yet — be the first.
Visited Dr. Thalange? Your experience helps others choose with confidence.
Write the first reviewReviews are written by signed-in users who attest to a visit, screened before publication, and labeled “Patient-reported” until visit verification launches. They are opinions, not medical advice.